Article
Novartis has pulled its TV ad for Lamisil from the air after receiving a letter from the FDA objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal.
Navigating Challenges to Prepare for the Future of Telehealth
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: February 9-14
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
The Rx Recap: February 9-15
Daily Derm Times: February 14, 2025